Codivir, a COVID-19 and RNA virus antiviral medication, is being developed by Code Pharma, a Dutch pharmaceutical company. Through the utilization of new peptides, the global corporation also specializes in the research, manufacture, and commercialization of cost-effective medicines for other infectious and oncological diseases.
CEO and Founder of Code Pharma, Zyon Ayni, said on IssueWire: “The entire team of Code Pharma is very excited today. We are a company of people playing an important role in the race to develop a cure for COVID-19. Our drug Codivir, was first discovered at the Hebrew University in Israel and it has a very good safety profile and very impressive antiviral activity”.
